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The linkage between xenobiotic exposures and autoimmune diseases remains to be clearly defined.
However, recent studies have raised the possibility that both genetic and environmental factors act
synergistically at several stages or checkpoints to influence disease pathogenesis in susceptible
populations. These observations predict that individuals susceptible to spontaneous autoimmunity
should be more susceptible following xenobiotic exposure by virtue of the presence of predisposing
background genes. To test this possibility, mouse strains with differing genetic susceptibility to
murine lupus were examined for acceleration of autoimmune features characteristic of spontaneous
systemic autoimmune disease following exposure to the immunostimulatory metals nickel and
mercury. Although NiCI2 exposure did not exacerbate autoimmunity, HgCI2 significantly accelerated
systemic disease in a strain-dependent manner. Mercury-exposed (NZB x NZW)F1 mice had
accelerated lymphoid hyperplasia, hypergammaglobulinemia, autoantibodies, and immune complex
deposits. Mercury also exacerbated immunopathologic manifestations in MRL+/+ and MR -Ipr
mice. However, there was less disease acceleration in lprmice compared with MRL+/+ mice, likely
due to the fact that environmental factors are less critical for disease induction when there is strong
genetic susceptibility. Non-major histocompatability complex genes also contributed to mercury-
exacerbated disease, as the nonautoimmune AKR mice, which are H-2 identical with the MRL,
showed less immunopathology than either the MRL//pr or MRL+/+ strains. This study
demonstrates that genetic susceptibility to spontaneous systemic autoimmunity can be a
predisposing factor for HgCI2-induced exacerbation of autoimmunity. Such genetic predisposition
may have to be considered when assessing the immunotoxicity of xenobiotics. Additional
comparative studies using autoimmune-prone and nonautoimmune mice strains with different
genetic backgrounds will help determine the contribution that xenobiotic exposure makes
in rendering sensitive populations susceptible to autoimmune diseases. Key words: animal
model, autoimmunity, lupus, mercury, nickel, xenobiotic. - Environ Health Perspect 107(suppl 5):
729-735 (1999).
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Analysis of the role of xenobiotics in
autoimmunity, particularly in humans, is
hampered by identification of potentially
sensitive populations. Epidemiologic studies
have revealed associations between xenobi-
otic exposure and certain systemic autoim-
mune diseases (1,2) but do not identify
susceptible individuals. Conversely,
although it is appreciated that systemic
autoimmune diseases are under multigenic
control (3), identification ofthe genetic ele-
ments involved and whether they respond
to environmental exposures is in its infancy.
However, recent studies have raised the pos-
sibility that both genetic and environmental
factors act synergistically at several stages or
checkpoints of disease pathogenesis (3).
This exacerbating role for environmental
agents has been suggested by a number of
studies that have shown that exogenous
agents can accelerate the onset of auto-
immunity in animal models (4-7). These
studies predict that individuals susceptible
to spontaneous autoimmunity should be
more susceptible following xenobiotic expo-
sure by virtue of the presence ofpredispos-
ing background genes. Such accelerated
disease would be expected to more closely
resemble the immunologic features of idio-
pathic autoimmunity rather than that
induced by xenobiotic exposure in a non-
autoimmune-prone host.
The availability of animal models of
systemic autoimmune disease provides a
valuable resource with which to study
the responses of a population sensitive to
xenobiotic-induced acceleration of auto-
immunity. Among the best-known animal
models ofhuman systemic autoimmune dis-
ease are those mouse strains that sponta-
neously develop features of systemic lupus
erythematosus (SLE) (3,8,9). Each of the
lupus-prone strains has been derived from
different genetic backgrounds, which results
in both quantitative and qualitative differ-
ences in disease expression. In some cases
specific features ofautoimmune disease have
been ascribed to individual genetic defects in
individual strains (9). Lupus-prone strains
thus provide unique genetic backgrounds for
the study of xenobiotic influences on the
constellation of immunologic features that
comprise systemic autoimmunity. The
strains used in this study include (NZB x
NZW)F1 (NZBWF1) (H-2dIz) female mice,
which due to the influence ofsex hormones
develop systemic autoimmunity earlier in
life than their male counterparts (3,8). Also
examined were MRL (H-2k) mice, which
consist of two substrains, MRLIIpr and
MRL+/+ (3,8). In the MRLlIpr, autoimmu-
nity occurs very early in life and is associated
with massive lymphoproliferation due to
abnormal Fas (CD95) expression. In con-
trast, the MRL+/+ substrain, which has nor-
mal Fas expression, develops less severe
systemic autoimmune disease, with onset
considerably later in life than the MRL//pr.
In order to compare the influence of non-
major hisocompatability complex (MHC)
genes on xenobiotic acceleration ofautoim-
munity, the nonautoimmune strain AKR
(H-2k) from which the MRL substrains
derive their H-2 was also tested.
Xenobiotics selected for study were two
metals, mercury and nickel, known to pro-
duce distinctly different immunologic
responses. Mercury induces autoimmunity
in mice (10) and rats (11) and an immune-
mediated kidney disease in humans (12).
Mercury-induced autoimmunity (HgIA) in
rodents is associated with three major patho-
logic sequelae-lymphoproliferation, hyper-
gammaglobulinemia, and the development
ofautoimmunity-manifested as autoanti-
body production and immune complex dis-
ease (10,11). Elicitation of these pathologic
features is dependent on genetic back-
ground, with lymphadenopathy occurring in
most strains; autoimmunity is more
restricted, being controlled in large part by
the MHC (10). HgIA was initially thought
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to be a CD4+ T-helper (Th)2 response
because ofincreased levels ofpredominantly
interleukin (IL)-4, and IgGI autoantibodies
after HgCl2 exposure (13). However all
the features of systemic autoimmunity
(hypergammaglobulinemia, autoantibodies,
immune complex deposits) are now known
to be dependent upon the Thl cytokine
interferon (IFN)-y (14).
In contrast, exposure to nickel is associated
with allergic rather than autoimmune reac-
tions. Nickel elicits increases in nitric oxide
production (15), activation ofnuclear factor-
KB (16), and delayed-type hypersensitivity
(DTH) reactions in humans (17) and rodents
(18). Nickel-induced DTH is characterized
by the presence ofIFN-y-producing Thl and
ThO CD4+ T cells (19).
In this study, particular emphasis was
placed on the potential of these xenobiotics
to exacerbate the natural course ofsystemic
autoimmune disease in lupus-prone mice as
revealed by lymphadenopathy, elevations of
serum immunoglobulin, appearance of
autoantibodies, and immune complex
deposits. Although NiCl2 exposure had lit-
tle effect on autoimmunity, mercury signifi-
cantly accelerated systemic disease in a
strain-dependent manner. Thus, mercury
exposure exacerbated almost all features of
autoimmunity in NZBWFI mice. Mercury
also exacerbated immunopathologic features
in both MRL substrains, although less effect
on the humoral response was observed in
mice with the lprmutation. Non-MHC and
non-lpr genes contributed to the mercury-
exacerbated disease in the MRL, as H-2
identical nonautoimmune AKR mice
showed less immunopathology. These
studies suggest that autoimmune-prone
mice are useful models for nonhuman
studies on the effects of xenobiotics on
sensitive populations.
Materials and Methods
Mice
Female NZBWFI (H-2d/z), MRL-FaslPr
(MRL/Ipr) (H-2k), MRL/Fas+1+ (MRL+/+)
(H-2k), and AKR/J (H~2k) mice were
obtained from The Scripps Research Institute
Animal Colony (La Jolla, CA) and main-
tained under specific pathogen-free condi-
tions. All experimental procedures using
animals followed the guidelines set down in
the National Institutes ofHealth Guidefor
the Careand UseofLaboratoryAnimals (20).
TreatmentofMice
Groups ofup to eight mice (4 weeks ofage)
were injected subcutaneously twice per
week for 4 weeks with 100 pL phosphate-
buffered saline (PBS) containing 40 pg
HgCl2, 40 pg NiCl2, or PBS alone. Mice
were bled before the first injection and
sacrificed on day 30; serum was stored at
-70°C until use. Autopsies were performed
as previously described (21). Samples of
kidney and spleen were harvested for analy-
sis of immune complex deposition and his-
tology (see "Tissue Complex Deposits" and
"Light Microscopy").
DetectionofSerumAntibody
Antibodies nuclear antigens (ANA) were
detected using HEp-2 cell slides (Bion
Enterprises, Park Ridge, IL) as previously
described (22). Prior to assay, sera were
diluted 100-fold in PBS containing 0.1%
bovine gamma globulin (BGG), 0.5%
bovine serum albumin (BSA), 0.001%
gelatin, and 0.05% Tween 20. Goat anti-
mouse IgG-fluorescein isothiocyanate
(FITC) (Caltag Laboratories, South San
Francisco, CA) diluted 100-fold in PBS con-
taining 0.5% BGG, 0.1% BSA, and 0.05%
Tween 20 was used as detecting reagent.
Antifibrillarin (nucleolar) monoclonal anti-
body 72B9 (23) was used as control.
Intensity of fluorescence was graded on a
scale of0-4+, with 1+ considered positive.
Antichromatin antibodies were detected
by enzyme-linked immunosorbent assay
(ELISA) as previously described (24). Sera
were diluted 100-fold prior to assay, and chro-
matin-bound antibodies detected with horse-
radish peroxidase (HRP)-conjugated goat
antimouse IgG (Caltag Laboratories) diluted
2,000-fold. Antichromatin monoclonal anti-
body ID12 was used as positive control (25).
SerumImmunoglobulinQuantitation
Serum IgG, IgG1, and IgG2a levels were
quantified by ELISA, essentially as previ-
ously described (26). ELISA plates were
coated with 200 pL of2 pg/mL goat anti-
mouse kappa light chain antibody (Caltag
Laboratories) in PBS, and incubated
overnight at 4°C. Plates were postcoated for
1 hr with 0.1% gelatin in PBS, followed by
three washes with PBS-0.05% Tween 20.
Sera were diluted in serum diluent (26), and
incubated at room temperature while shak-
ing for 2.5 hr, followed by three washes with
PBS-0.05% Tween 20. HRP-conjugated
goat antimouse IgG, IgG1, or IgG2a anti-
bodies (Caltag Laboratories) diluted in anti-
immunoglobulin diluent (26) were added
before incubation with shaking for 90 min.
After three washes with PBS-0.05% Tween
20 and four washes with PBS, 2,2'-
azinobis(3-ethylbenzthiazolinesulfonic acid)
(ABTS) substrate solution was added and
optical density read at 405 nm (OD405).
Standard curves were generated by serial
dilutions of polyclonal mouse reference
serum containing predetermined levels of
immunoglobulin isotypes and subclasses
(The Binding Site, Birmingham, UK).
Serum IgG, IgGI, and IgG2a concen-
trations were quantified by converting the
average OD405 of duplicate wells to
immunoglobulin concentrations by use of
standard curves. Only serum dilutions that
gave OD405 values falling within the linear
portion of the standard curve were used to
calculate immunoglobulin levels.
TissueImmune Complex Deposits
Sections 2- to 3-mm thick ofthe kidney and
spleen were snap frozen in isopentane-C02
and prepared for direct immunofluorescence
as previously described (27). Cryostat sections
4- to 5-pm thick were fixed in ethanol and
incubated with serial dilutions ofFITC-con-
jugated goat antibodies to IgG (,y-chain spe-
cific) or C3 (Southern Biotechnology
Associates, Birmingham, AL). The end-point
titer of the immune complex deposits was
defined as the highest dilution ofantibody at
which specific fluorescence could be detected
and was expressed as the reciprocal titer. A
score of0 was recorded when no specific fluo-
rescence was detected at a dilution of 1/40.
The presence ofgranular deposits in small and
medium-size arteries was also examined. All
histology slides were examined without
knowledge oftreatment given orother results.
LightMicrspy
A 2- to 3-mm thick section ofkidney was
immersed in Histochoice fixative (Amresco,
Solon, IL), embedded in paraplast, and cut
into 1- to 2-pm sections that were stained
with periodic acid Schiff's reagent and with
periodic acid silver methenamine. Slides were
then examined by light microscopy without
knowledge of treatment given or other
results. The types ofglomerular alteration
were determined and the degree ofendocapil-
lary cell hyperplasia was scored for each ani-
mal as follows: 0 = normal, 0.5 = just
detectable alteration, 1 = slight, 2 = moderate,
3 = strong, and 4 = maximal.
StatisticalAnalysis
Groups were compared by single-factor
ANOVA, Mann-Whitney Utest, or Fisher's
exact test, as appropriate. Comparisons are of
HgC12-treated mice with PBS- and NiCI2-
treated animals unless described otherwise.
p < 0.05 was considered significant.
Results
EffctofHlgCI2andNiC12onFears
ofAutoimmu nit inNZBWF1 Mice
Mercury-exposed NZBWFI mice had ele-
vated serum IgG, IgG1, and IgG2a compared
to PBS- and NiCl2-exposed animals (Table 1,
Figure 1). Antibody to nuclear antigens
(ANA) (Table 1) ofa predominantly dense
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fine to homogenous nuclear speckling of
interphase cells and metaphase chromo-
somes was found in all NZBWF1 mice
exposed to HgC12. All pretreatment sera as
well as PBS- and NiCI2-treated mice showed
less frequent ANA responses. Levels of
antichromatin antibodies (Table 1, Figure 1)
in HgCl2-exposed NZBWF1 mice were
markedly elevated above those found in
either NiCl2- or PBS-exposed animals.
Exposure ofNZBWF1 mice to mercury
increased organ wet weight ofspleen and
cervical lymph nodes but not mesenteric
lymph nodes when compared to PBS- and
NiCl2-treated animals (Table 2). All HgC12-
treated mice developed very high titers of
IgG and C3 deposits in glomeruli (Table 2).
Granular IgG deposits in the glomeruli were
localized to the capillary loops in 3/8 mice,
restricted to the mesangium in one mouse,
Table 1. Immunoglobulin levels and autoantibodies in NZBWF1 micefollowing metal exposure.ab
Immunoglobulin level
Strain lgG IgGl lgG2a ANA Antichromatin
(sex) No. Treatment (mg/mL) (mg/mL) (mg/mL) (pos/no.) (OD405)
NZBWF1 8 Pre-PBS 1.44 ± 1.07 0.20 ±0.08 0.47 ±0.22 0/8 0.02 ±0.01
(female) Post-PBS 2.64 ±0.94 0.30 ±0.08 1.50 ±0.50 0/8 0.06 ±0.05
8 Pre-NiCI2 1.69 ± 0.65 0.28 ± 0.06 0.74± 0.34 0/8 0.04 ± 0.02
Post-NiCI2 3.17 ± 1.38 0.30 ± 0.06 2.06 ±0.86 1/8 0.04 ±0.03
8 Pre-HgCI2 1.56 ±0.05 0.41 ± 0.11 0.96 ± 0.25 0/8 0.06 ±0.04
Post-HgCI2 10.58 ±2.351 3.06 ± 1.54+ 8.10 ± 1.70 8/8 1.27 ±0.651
Abbreviations: OD4,s, optical density read at 405 nm; PBS, phosphate-buffered saline; pos/no., positive/number ofanimals. 'p-values
are from comparison of mercury-treated group with PBS- and nickel-treated groups. +p< 0.0002; tp< 0.0001. bData are expressed as
mean ±standard deviation.
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Figure 1. Hypergammaglobulinemia and
antichromatin antibodies in NZBWF1 mice after
exposure to mercury. OD405, optical density
read at 405 nm; PBS, phosphate-buffered
saline. Female NZBWF, mice were injected
with HgCI2, NiCI2, or PBS for 4 weeks as
described in "Materials and Methods." Serum
IgG, IgGl, and IgG2a (left panels) were deter-
mined by enzyme-linked immunosorbent assay
(ELISA) before (o) and after (c) metal expo-
sure. lgG antichromatin antibodies(rightpanel)
were determined by ELISA before(o) and after
(.) metal exposure. See Table 1 for statistical
analysis.
and present along the capillary loops as well
as in the mesangium in the remaining four
mice. Granular deposits ofC3 were found in
the mesangium in 6/8 animals, whereas 2/8
mice showed C3 deposits along the capillary
loops as well as in the mesangium. Renal and
splenic vessel walls showed granular deposits
with high titers ofIgG and C3. In contrast,
mice treated with NiCl2 or PBS had much
lower titers of IgG in the glomerular
mesangium in 2/8 and 3/8 mice, respec-
tively, without any deposits along the capil-
lary loops. The titers ofC3 in the glomeruli
were also significantly lower in these mice.
None ofthe NiCl2- or PBS-treated animals
showed deposits of IgG or C3 in the renal
or splenic vessel walls. Histologically there
was only slight endocapillary cell hyperpla-
sia in the glomeruli, which did not differ
among the three treatment groups, probably
because of the young age of mice at sacri-
fice. There were no alterations in the
glomerular basement membrane among the
three treatment groups.
EffectofHgC12 andNiCI2 on Features
ofAutoimmunity inMRIJWprMice
Metal exposure did not lead to elevations of
immunoglobulin in MRL/Ipr mice, as all
three treatment groups developed hyper-
gammaglobulinemia during the experimen-
tal period (Table 3, Figure 2). Metal- and
saline-exposed MRL/Ipr mice showed no
significant differences in ANA and
antichromatin antibody at the end of the
treatment period; each ofthe groups devel-
oped antichromatin antibodies during the
exposure period (Table 3, Figure 3).
Mercury-exposed MRL/Ipr mice had
larger mesenteric lymph nodes than PBS- or
NiCI2-treated animals but showed no differ-
ence in cervical node or spleen weights
(Table 4). Mercury treatment increased the
incidence of glomerular, mesangial IgG
deposits in all MRLIIprmice compared with
5/8 mice treated with NiCl2 and only 2/8
PBS-treated animals (Table 4). Mercury sig-
nificantly increased the titer ofmesangial IgG
and C3 deposits (Table 4). No vessel wall
deposits were seen in any of the animals.
There was a mild endocapillary cell hyperpla-
sia in theglomeruli, which tended to be more
pronounced in the HgCl2-treated group, but
this did not reachstatisticalsignificance.
Table 2. Pathologicchanges in NZBWF, micefollowing metal exposure.abc
Organ wetweight(mg) Kidney immunopathology Spleen immunopathology
Strain Cervical Mesenteric Glomerular Glomerular Vessel Vessel Vessel Vessel
(sex) No. Treatment Spleen LN LN lgG C3 IgG C3 lgG C3
NZBWF1 8 PBS 87±3 32±2 107±5 25±37 480±171 0 0 0 0
(female) 8 NiCI2 89 ±3 29 ±3 107 ±8 20 ±37 330± 151 0 0 0 0
8 HgCI2 129 ±5 70±61 97 ±6 1760 ± 6620 1440 ± 4530 1600± 5930 1160± 3390 1280± 593 1400± 7460
PBS, phosphate-buffered saline. "p-values are from comparison ofmercury-treated group with PBS- and nickel-treated groups. #p<0.001; tp< 0.0001. hData are expressed as mean ± standard deviation.
9gG and C3titers areexpressed asreciprocal titers.
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Table3. Immunoglobulin levels and autoantibodies in MRLmicefollowing metal exposure.ab
Immunoglobulin level Anti-
Strain lgG IgGl IgG2a ANA chromatin
(sex) No. Treatment (mg/mL) (mg/mL) (mg/mL) (pos/no.) (OD40)
MRL/lpr 8 Pre-PBS 2.71 ±2.10 1.03 ±0.67 3.45 ±2.74 0/8 0.02 ±0.05
(female) Post-PBS 9.58 ±4.44 3.66 ± 1.25 6.06 ± 2.85 4/8 0.35± 0.43
8 Pre-NiCI2 2.11+0.71 0.82+0.45 1.88+0.83 1/8 0.01+0.01
Post-NiCI2 10.41 ±3.17 3.45 ± 1.02 4.48 ± 1.56 8/8 0.70±0.46
8 Pre-HgCI2 1.30 ± 0.33 0.79 ± 0.16 1.25 ± 0.54 1/8 0.03 ± 0.01
Post-HgCI 8.65 ±3.38 4.07 ± 2.53 4.62 ± 1.46 7/8 0.56 ±0.43
MRL+/+ 8 Pre-PBS 2.93±4.32 1.17 ±2.15 1.45±2.47 5/8 0.10± 0.15
(female) Post-PBS 4.06 ± 2.71 1.45 ± 1.40 2.01 ± 2.04 7/8 0.17 ± 0.16
8 Pre-NiCI2 1.71 ±1.14 0.46 ± 0.27 0.64 ± 0.31 6/8 0.57 ± 1.20
Post-NiCI2 3.92 ±2.43 1.29 ±0.86 1.81 ± 1.05 7/8 0.48± 0.48
8 Pre-HgCI2 1.44 ±0.69 0.41 ±0.14 0.72 ± 0.44 4/8 0.38±0.64
Post-HgCI2 7.12±1.76§ 3.47 ±0.87+ 3.68±1.84 8/8 1.88 ± 1.71*
Abbreviations: OD4%, optical density read at405 nm; PBS, phosphate-buffered saline; pos/no., positive/number ofanimals. 'p-values are from comparison ofmercury-treated groupwith PBS- and nickel-
treated groups. *p<0.05;sp<0.02; +p<0.005.&Data areexpressed as mean +standard deviation.
20-
18-
16-
14-
i 12
lgG -. 10-
E 8-
6-
4-
2 -
MRL/lpr
a 0
* a 0
* 0
0
MRL+/+
0
Sb 0
0
4 oh
$
CD4
0
AKRIJ
CO
0
0
8-
6 0
4-
a
0 o
0
2- 0 0 t
2 S5t (&b
o~o
12-
10- O'
8-
0 0~~~
6- ;
2- 8 0- % 0n0 0 0
2 &
PBS Ni Hg
0
0
S
* a
0
0
0
- o
0
- 0 0
0 N
PBS Ni Hg
j
0
0
*0
PBS Hg
Figure2. Hypergammaglobulinemia in MRLandAKR mice after exposure to mercury. PBS, phosphate-buffered saline. Female MR//pr, MRL+/+andAKR mice were injected with
HgCI2, NiCI2, or PBS for 4weeks as described in "Materials and Methods." Serum IgG, IgGl, and IgG2a were determined by enzyme-linked immunosorbent assay (ELISA) before
(o)and after(c)metal exposure. SeeTables 3and 5forstatistical analysis.
F&c'tofHgC12and NiCi2 on F s
ofA mmunityinMRL+/+ Mice
Mercury-exposed MRL+/+ mice had elevated
serum IgG and IgGI compared to PBS- and
NiCl2-exposed animals, whereas IgG2a levels
were elevated compared to NiCl2-treated mice
(Table 3, Figure 2). A variety ofANA patterns
were found in MRL+/+ mice before and after
the various treatments (data not shown).
Mercury treatment ofMRL+/+ mice resulted
in elevated levels ofantichromatin antibodies,
which were significantly different from PBS-
andNiCI2-treated animals (Table3, Figure3).
Mercury-exposed MRL+/+ mice had
larger cervical nodes than their control
counterparts, but spleen weights were not
increased and mesenteric nodes were smaller
(Table 4). All MRL+I+ mice treated with
HgCl2 showed glomerular and mesangial IgG
deposits, whereas only 5/8 NiGC2-treated mice
and 3/8 PBS-treated mice showed such
deposits (Table 4). Renal vessel wail deposits
ofIgG were seen in 7/8 and C3 in 2/8 ofthe
HgC12-treated MRL+/+ mice. Only one
Environmental Health Perspectives * Vol 107. Supplement 5 * October 1999
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Figure 3. Antichromatin antibodies in MRL and AKR mice after metal exposure. 0D34%, optical density read at405 nm; PBS, phosphate-buffered saline. Female MRL/Ipr, MRL+/+,
and AKR mice were injected with HgCI2, NiCI2, or PBS for 4 weeks as described in "Materials and Methods." lgG antichromatin antibodies were determined by enzyme-linked
immunosorbent assay(ELISA) before(o)and after(c) metal exposure. SeeTables 3 and 5forstatistical analysis.
Table 4. Pathologic changes in MRL micefollowing metal exposure.ab
Organ wetweight(mg) Kidney immunopathologyc
Strain Cervical Mesenteric Glomerular Glomerular Vessel Vessel
(sex) No. Treatment Spleen LN [N lgG C3 lgG C3
MRL/Ipr 8 PBS 193±177d 63±21 141±29 60±119 295±406 0 0
(female) 8 NiCI2 175±66 83±13 178±11 120±135 220±111 0 0
8 HgCI2 180 ±89 195 ± 114 227± 15§ 470±384*.fe 680 +267* 0 0
MRL+/+ 8 PBS 95±3 57±5 196±17 60±111 270±95 0 0
(female) 8 NiCI2 97 ±6 49± 1 182 ±7d 140± 134 300± 159 0 0
8 HgCI2 104 ±5 69±31 135± 12+ 300± 217*,e 490±398 380+ 410 ,*,e 240±476
PBS, phosphate-buffered saline. Data are expressed as mean ± standard deviation. 'bpvalues are from comparison of mercury-treated groupwith PBS and nickel-treated groups. *p< 0.05; §p<0.02; fp<
0.01; +p<0.005; tp<0.0001. cgG and C3titers areexpressed as reciprocal titers. Sdata from7 animals. 'p-valuesforincreased incidence ofrespective pathology.
Table 5. Immunoglobulin levels and autoantibodies in AKR micefollowing metal exposure.ab
Immunoglobulin level
Strain lgG IgG1 IgG2a ANA Antichromatin
(sex) No. Treatment (mg/mL) (mg/mL) (mg/mL) (pos/no.) (OD405)
AKR 8 Pre-PBS 2.05± 0.83 0.25± 0.12 1.52±0.86 1/8 0.02± 0.01
(female) 7 Post-PBS 2.84 ±0.47 0.70 ± 0.32 2.95 ± 0.68 1/7 0.01 ± 0.00
Pre-NiCI2 ND ND ND ND ND
Post-NiCI2 ND ND ND ND ND
8 Pre-HgCI2 2.22 ±0.49 0.38 ±0.16 1.69 ±0.30 1/8 0.01 ± 0.01
7 Post-HgCI2 5.21 ±1.99+ 1.19±0.56 5.44± 1.67+ 6/7 0.12 ±0.01f
Abbreviations: ANA, antibodies to nuclear antigens; ND, not done; 0D14%, optical density read at 405 nm; PBS, phosphate-buffered
saline; pos/no., position/number of animals. p-values are from comparison of mercury-treated group with PBS and nickel-treated
groups. fp< 0.01; +p< 0.005.&Data areexpressed as mean± standard deviation.
animal had deposits of Ig and C3 in splenic
vessel walls. Vessel wall deposits were not
found in either the kidney or spleen ofPBS-
and NiCl2-treated animals. Compared with
PBS-treated animals, there was significantly
increased focallsegmental hyperplasia ofendo-
capillary cells in the mercury group (0.59
0.23 vs 1.25 ± 0.13; p < 0.001).
EflFct ofHgC02 andNiCI2 on Features
ofAutoimmunityinAKR Mice
AKR mice also developed hypergamma-
globulinemia with increases in IgG and
IgG2a following HgCl2 exposure (Table 5).
Mercury-treated AKR mice developed ANA
but only low levels ofantichromatin antibod-
ies (Table 5). Compared to PBS controls,
mercury-exposed AKR mice had significant
increases ofIgG (51 ± 55 vs 274 ± 78; p <
0.0001) and C3 (34 ± 28 vs 120 ± 52; p <
0.005) deposits in the mesangium ofthe kid-
ney glomeruli. There were no deposits in the
kidney vessels or spleen ofAKR mice and no
histologic abnormalities bylight microscopy.
Discussion
The exacerbation by mercury ofsystemic
autoimmunity in lupus-prone mice identifies
a potential model for the study ofxenobiotic
effects on autoimmune-sensitive populations.
The autoimmune features and the extent to
which they were accelerated differed between
the stains tested, suggesting that genetic back-
ground influenced the response to xenobiotic
exposure. Much ofthe disease acceleration
appeared to be due to non-MHC lupus-
predisposing genes, as an MHC-matched
nonautoimmune strain had less severe disease
manifestations. Strain-dependent responses,
as well as the importance ofnon-MHC genes
in disease severity, suggest that xenobiotic
exposure led to acceleration ofidiopathic dis-
ease beyond the induction of HgIA.
Acceleration ofautoimmunity was dependent
on the specific immunostimulant; another
metal that can activate the immune system,
nickel, had littleeffect.
The most pronounced response to
mercury exposure was observed in female
NZBWF1 mice, considered to be the proto-
typic murine model for human lupus (11).
This strain exhibited lymphadenopathy in the
spleen and the cervical lymph nodes, which
drain the mercury injection site. NZBWF1
mice also had pronounced hypergamma-
globulinemia. Most striking was the marked
elevation in antichromatin autoantibodies-
an autoantibody response characteristic of
murine lupus (28) and idiopathic (29) and
drug-related human lupus (30) but found less
frequently in murine HgIA (31). Extensive
tissue deposits ofimmunoglobulin and com-
plement, particularly in the vessels ofthe kid-
ney, are consistent with the progressive
glomerulonephritis ofidiopathic disease in
NZWBF1 mice (32). The higher titer of
glomerular deposits in the NZBWF1 com-
pared to the MRL substrains is also consistent
with the idiopathic picture in these strains
(32). These studies with mercury, and those
with other exogenous agents (4,7), suggest
that the NZBWF1 strain may be particularly
suited to studies on xenobiotic-induced exac-
erbation ofsystemic autoimmunity.
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The MRL/Iprhas been used extensively in
studies on autoimmunity, primarily to under-
stand the significance ofthe lprgene but also
because its accelerated disease and early mor-
tality facilitate in vivo studies. However, the
long life ofthe MRL+/+ offers the advantage
ofexamining the effects oflong-term xenobi-
otic exposures on the expression ofautoim-
munity. Previous studies have suggested that
autoimmunity in MRL mice is either acceler-
ated (33,34) or unaffected (33) byxenobiotic
exposure. Both MRL substrains were exam-
ined in this study to determine ifthe acceler-
ated disease ofthe MRL/Ipr, and the delayed
disease ofthe MRL+/+, would be similarly
affected by exposure to metals. The presence
ofthe Iprgene, which is associated with eleva-
tions ofIgG andANA as early as 2 months of
age (32,35), appeared to be the predominant
influence on immunoglobulin and autoanti-
body levels, as neither metal led to increases
above those ofthe PBS controls. In contrast,
mercury-exposed MRL+/+ mice showed evi-
dence of both accelerated hypergamma-
globulinemia and elevated antichromatin
antibodies compared to nickel- or PBS-treated
groups. Interestingly, both MRL substrains
had increased glomerular deposits of IgG
compared with those in control mice, and
MRL+/+ mice showed more severe
immunopathology with IgG and C3 deposits
in kidney vessels as well as hyperplasia of
endocapillary cells. The increased glomerular
disease in Iprmice exposed to HgC12 despite
similar levels ofimmuloglobulins and autoan-
tibodies as PBS and NiCI2 controls suggests
that HgCl2 may also promote disease by
mechanisms beyond autoantibody produc-
tion, possibly related to autoantibody speci-
ficity or effector pathways involved in
end-organ damage.
The MHC is a major contributor to both
idiopathic lupus (3) and HgIA (31,36). It
could therefore be argued that exacerbation of
autoimmunity in lupus-prone mice is primar-
ily due to an effect on H-2 genes and not
acceleration ofidiopathic disease per se. To
examine this possibility, AKR mice, from
which the MRL derives its H-2 genes, were
exposed to mercury. Although the AKR pos-
sesses the H-2k haploytpe, which confers sus-
ceptibility to HgIA (31), the degree of
autoimmunity elicited differed from that of
MRL mice. AKR mice had predominant ele-
vations of IgG2a, whereas MRL+/+ mice
showed increased IgGl. HgC12-exposed
MRL+/+ mice had more severe disease, with
higher titers of antichromatin antibodies,
increased deposits ofIgG and C3 in kidney
vessels, and histologic glomerular changes.
This comparison between autoimmune-prone
strains and an H-2 identical nonautoimmune
strain demonstrates the influences of both
non-MHC and non-Ipr genes on mercury-
accelerated systemic autoimmunity in mice
predisposed to spontaneous disease.
Furthermore, the data demonstrate how an
environmental agent, mercury, can act syner-
gistically on individuals with intermediate
susceptibility (NZBWFI and MRL+/+) to
accelerate disease, whereas there was less effect
on MRLIlpr mice with the highest suscepti-
bility. This is consistent with the threshold
liability model (9) and the potential impor-
tance ofenvironmental factors in influencing
disease induction, particularly in individuals
with intermediate susceptibility.
Mercury, in various forms, elicits systemic
autoimmunity in a number of nonauto-
immune murine strains (10). Susceptibility to
HgIA is genetically controlled, as this xenobi-
otic is able to elicit differing degrees of
autoimmunity depending upon the genetic
background of the host (10,27). The
immunologic features ofHgIA, which include
lymphadenopathy, hypergammaglobulinemia,
autoantibodies, and immune complex disease,
resemble features ofSLE. Even so, there are
significant differences between murine models
of HgIA and idiopathic SLE. HgIA is tran-
sient, with disease features resolving with time
once exposure to mercury ceases (27). In idio-
pathic SLE, disease is progressive, often lead-
ing to death (8,9). At the height ofdisease
HgIA is associated with increased IL-4 and
IgG1 autoantibodies (13). In contrast, murine
models ofidiopathic SLE have autoantibodies
of IgG2a and IgG2b isotypes (28) and
elevations in IL-1 and IFN-,y(9).
Several mechanisms have been postulated
to account for mercury's autoimmune-
promoting effects, including generation of
cryptic T-cell determinants (37) or produc-
tion ofT cells reacting against self-class II
(38). The finding that mercury did not accel-
erate humoral responses in the presence ofthe
lpr gene raises the possibility that mercury,
like the Iprdefect, may act through inhibition
ofapoptosis. This would be consistent with
the polyclonal lymphoid hyperplasia and
immunoglobulin increases found in the
MRL+/+ after mercury treatment. Mercury
could possibly prevent apoptosis by interact-
ing with the sulfhydryl moiety ofcysteine in
the active site ofone or more caspases (39)
that are involved in the signaling and effector
pathways responsible for induction of
apoptoticcell death.
Comparison between the MRL and AKR
strains revealed the importance ofstudies with
genetically related nonautoimmune strains in
dissecting the contribution ofxenobiotic expo-
sure to acceleration of idiopathic disease.
Additional studies contrasting the genetically
related autoimmune-prone BXSB (H-2b) and
nonautoimmune C57BL/6 (H-2b) have also
shown that mercury exposure exacerbates idio-
pathic autoimmunity (40). The significance of
such studies cannot be overstated. Human
studies have shown that xenobiotic-induced
disease, although exhibiting features ofthe
idiopathic syndrome, may lack key pathologic
sequlea and have dinical features not associ-
ated with idiopathic disease (2,41). Studies
that seek to link xenobiotics with auto-
immunity must therefore attempt to
discriminate between xenobiotic-induced
autoimmunity andxenobiotic-accelerated idio-
pathic disease. Comparative studies using
genetically related autoimmune-prone and
nonautoimmune mice might help determine
the contribution that xenobiotic exposure
makes in rendering sensitive populations
susceptible to autoimmunity.
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